Silver Book Fact

Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349 in women 50- to 59-years-old, and $74,981 in women 60 to 69.

Joint Economic Committee. The Benefits of Medical Research and the Role of NIH. Apr-2000;

Reference

Title
The Benefits of Medical Research and the Role of NIH
Publisher
United States Senate: Office of the Chairman, Connie Mack
Publication Date
Apr-2000
Authors
Joint Economic Committee

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • Medicines in Devlopment for Cancer, 2008  
  • New cancer treatments account for large percent of life expectancy gains
     
  • Reductions in mortality for lung, female breast, prostate, and colorectal cancers accounted for 60 to 80 percent of the total decrease in all cancer deaths since the early 1990s.  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.